SogoTrade Research Center

For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
JP Morgan Chase & Company
(NYSE: JPM) Add to Portfolio
-0.32 (-0.24%)
as of Dec 11, 2019

Last 134.18
Change -0.32 (-0.24%)
Open 134.29
Prev. Close 134.50
Today's Range
134.01 135.02
52wk Range
91.11 135.78
Volume 9,012,400
Avg Volume 8,966,800
Sector SIC-6021 National Commercial Banks

Recent Headlines
Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at the Westin St. Francis Hotel in San Francisco, and will pr (full story)
JPM: 134.18 (-0.32), XENT: 20.91 (+0.10)
via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, announced its 2020 Cell & Gene Therapies St (full story)
JPM: 134.18 (-0.32)
Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that it has priced an underwritten publi (full story)
JPM: 134.18 (-0.32), CNST: 36.09 (+0.58)
Phreesia, Inc. ("Phreesia") (NYSE: PHR), a leading patient intake management platform, announced today the launch of an underwritten secondary public offering of a total of 6,000,000 shares of its common stock (the "Secondary Offe (full story)
JPM: 134.18 (-0.32), WFC: 53.17 (-0.52), PHR: 28.66 (-0.17)
The Board of Directors of JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") declared a quarterly dividend on the outstanding shares of the common stock of JPMorgan Chase. Information can be found on the Firm's Inve (full story)
JPM: 134.18 (-0.32)
Performance Comparison
Name Today 3-Month 1-Year
JPM -0.24% +16.12% +33.69%
Growth Rates
YTD +37.45%
1-Year +34.11%
3-Year +58.35%
5-Year +117.18%
10-Year +222.77%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.